TABLE 3.
Cross-VN assay using representative plasma samplesa
Sample (source) | VN titer against strain:
|
|
---|---|---|
Yanaka | Onderstepoort | |
FB-1 (a) | 80 | 60 |
TC-1 (b) | 160 | 80 |
TC-2 (b) | 80 | 40 |
TS-1 (c) | 40 | 30 |
TS-2 (c) | 120 | 40 |
TS-3 (c) | 320 | 240 |
TS-4 (c) | 240 | 240 |
TS-5 (d) | 400 | 320 |
TS-6 (d) | 160 | 240 |
TS-7 (d) | 160 | 80 |
TS-8 (d) | 120 | 40 |
TS-9 (d) | 80 | 40 |
SP-1 (e) | 160 | 320 |
TK-1 (f) | 1,280 | 320 |
TK-2 (f) | 80 | 40 |
TK-3 (f) | 40 | 20 |
TK-4 (f) | 20 | <20 |
D-1 (g) | 320 | 160 |
D-2 (g) | 480 | 160 |
D-3 (g) | 160 | 80 |
D-4 (g) | 240 | 120 |
H-1 (h) | 80 | 20 |
H-2 (h) | 30 | <20 |
H-3 (h) | 160 | 20 |
CDV-seropositive samples in Taiwan were obtained from a leopard cat (a) and domestic cats (b) in Taichung in 1993 and in Tam-Sui in 1993 (c) and 1998 (d). CDV-seropositive samples in Japan were collected from domestic cats in Sapporo in 1982 (e) and in Tokyo in 1998 (f, g, and h). D-1 to D-4 were cats kept as blood donors in veterinary hospital A. H-1 to H-3 were Haemobartonella-infected cats kept in the same hospital.